ATS 2018 International Conference - Mobile

Victor Balaguer

MSc, MEng

AstraZeneca

Session(s)

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial of AZD8871, a Novel Dual-Act...
Monday, May 21 9:15 AM - 9:30 AM
An Ascending, Repeat-Dose Safety and Tolerability Study of AZD8871 a Novel, Dual-Acting Br...
Tuesday, May 22 11:15 AM - 1:00 PM